Chemotherapy and Radiation
710 articles
A Liquid Biopsy for Pancreatic Cancer
Dr. Bert Vogelstein and his team at Johns Hopkins are working with a blood test called a liquid biopsy, which tests cells for mutations related to cancer.
New NCCN Guidelines Stress Genetic Testing For All Pancreatic Cancer Patients
Genetics impact your treatment for pancreatic cancer. Dr. Sapna Syngal discusses the recommendation of genetic testing for all pancreatic cancer patients.
KRYSTAL-1 Trial Shows Promising Activity in Pancreas and Other GI Cancers
Dr. Tanios Bekaii-Saab reports promising results of the KRYSTAL-1 trial, which targets a KRAS mutation common to pancreatic cancer.
COVID-19 and Pancreatic Cancer Clinical Trials
How is the COVID-19 pandemic affecting clinical trials? Learn more about what steps are being taken to protect patients on trials, plus more.
Who Should Be Screened For Pancreatic Cancer
Who should be screened for pancreatic cancer? Dr. Allyson Ocean explains how genetic mutations and family history factor into screening.
Finding the Best Diabetes Drug for Pancreatic Cancer Patients
With all the various drugs out there, Dr. James Flory wants to establish which diabetes drug works best for pancreatic cancer patients. Read his expert advice.
Comparing Chemotherapy Before with Chemotherapy After Pancreatic Cancer Surgery
Researchers are comparing effectiveness of chemotherapy before surgery (neoadjuvant) with chemotherapy after surgery (adjuvant).
Two-Drug Combo Targets KRAS and Fights Resistance
Researcher Hervé Tiriac leads a clinical trial for a new drug combination targeting KRAS and chemotherapy resistance.
Diagnosing Pancreatic Cancer: Tests to Expect
What can you expect during pancreatic cancer diagnostic testing? Dr. Gobind Anand offers expert guidance to stay informed throughout the process.
Clinical Trial For OncoTreat Being Developed
Researcher Kenneth Olive is developing OncoTreat, a method matches a patient’s tumor to the most effective drugs for their pancreatic cancer.
Can AI Help Detect Pancreatic Cancer Early?
Dr. Mimi Canto is leading a cross-disciplinary group of researchers who are working to use AI for early detection of pancreatic cancer.
Adaptive Pre-Surgery Therapy for Patients with Localized Pancreatic Cancer
Will a flexible approach to neoadjuvant treatment work better for pancreatic cancer patients with tumors that can be removed surgically?
Platform Trial Design Aims to Get Information Quickly and Efficiently
Dr. Eugene Koay is leading a platform trial, for a more nimble way to adapt to participants’ response to treatments being tested.